Harikrishna Devalapally

3.5k total citations · 1 hit paper
17 papers, 2.8k citations indexed

About

Harikrishna Devalapally is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Harikrishna Devalapally has authored 17 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Biomaterials and 5 papers in Pharmaceutical Science. Recurrent topics in Harikrishna Devalapally's work include Nanoparticle-Based Drug Delivery (9 papers), Advanced Drug Delivery Systems (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Harikrishna Devalapally is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Advanced Drug Delivery Systems (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Harikrishna Devalapally collaborates with scholars based in United States, India and Mexico. Harikrishna Devalapally's co-authors include Mansoor M. Amiji, Srinivas Ganta, Aliasgar Shahiwala, Michael V. Seiden, Zhenfeng Duan, Dinesh B. Shenoy, Róbert Langer, Steven R. Little, Mayank Bhavsar and Judy Chen and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Harikrishna Devalapally

17 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of stimuli-responsive nanocarriers for drug and gene delivery

2008 1.8k citations Srinivas Ganta, Harikrishna Devalapally et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harikrishna Devalapally United States	15	1.4k	955	946	518	452	17	2.8k
Mariano Licciardi Italy	34	1.4k 1.0×	829 0.9×	865 0.9×	599 1.2×	517 1.1×	123	3.2k
Srinivas Ganta United States	21	1.9k 1.3×	1.2k 1.3×	1.3k 1.4×	594 1.1×	546 1.2×	31	3.7k
Stefano Salmaso Italy	34	1.6k 1.1×	1.2k 1.2×	1.5k 1.6×	514 1.0×	358 0.8×	110	3.8k
Shawn C. Owen United States	23	1.2k 0.9×	880 0.9×	948 1.0×	639 1.2×	251 0.6×	43	3.0k
Daria Y. Alakhova United States	12	1.4k 1.0×	810 0.8×	1.3k 1.4×	370 0.7×	366 0.8×	20	2.9k
Peisheng Xu United States	32	1.3k 0.9×	1.2k 1.2×	1.3k 1.4×	399 0.8×	440 1.0×	63	3.3k
Katrin Knop Germany	14	1.5k 1.1×	983 1.0×	1.3k 1.4×	898 1.7×	497 1.1×	22	3.6k
Motoi Oishi Japan	32	1.2k 0.9×	922 1.0×	2.0k 2.1×	568 1.1×	511 1.1×	73	3.5k
Cristianne J.F. Rijcken Netherlands	28	2.2k 1.5×	1.2k 1.3×	1.1k 1.1×	1.1k 2.1×	456 1.0×	59	3.6k
Menghua Xiong China	31	1.5k 1.1×	1.4k 1.5×	1.7k 1.8×	817 1.6×	665 1.5×	56	3.9k

Countries citing papers authored by Harikrishna Devalapally

Since Specialization

Citations

This map shows the geographic impact of Harikrishna Devalapally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harikrishna Devalapally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harikrishna Devalapally more than expected).

Fields of papers citing papers by Harikrishna Devalapally

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harikrishna Devalapally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harikrishna Devalapally. The network helps show where Harikrishna Devalapally may publish in the future.

Co-authorship network of co-authors of Harikrishna Devalapally

This figure shows the co-authorship network connecting the top 25 collaborators of Harikrishna Devalapally. A scholar is included among the top collaborators of Harikrishna Devalapally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harikrishna Devalapally. Harikrishna Devalapally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Devalapally, Harikrishna, et al.. (2013). Evaluation of a Nanoemulsion Formulation Strategy for Oral Bioavailability Enhancement of Danazol in Rats and Dogs. Journal of Pharmaceutical Sciences. 102(10). 3808–3815. 18 indexed citations

Devalapally, Harikrishna, et al.. (2013). Optimization of PEGylated nanoemulsions for improved pharmacokinetics of BCS class II compounds. Drug Delivery. 22(4). 467–474. 22 indexed citations

Holmes, Eric H., Harikrishna Devalapally, Libin Li, Michael L. Perdue, & Gary K. Ostrander. (2013). Permeability Enhancers Dramatically Increase Zanamivir Absolute Bioavailability in Rats: Implications for an Orally Bioavailable Influenza Treatment. PLoS ONE. 8(4). e61853–e61853. 14 indexed citations

Devalapally, Harikrishna, et al.. (2011). An improved synthesis of lysosomal activated mustard prodrug for tumor-specific activation and its cytotoxic evaluation. Drug Development and Industrial Pharmacy. 38(9). 1047–1053. 3 indexed citations

Ganta, Srinivas, Harikrishna Devalapally, & Mansoor M. Amiji. (2010). Curcumin Enhances Oral Bioavailability and Anti-Tumor Therapeutic Efficacy of Paclitaxel upon Administration in Nanoemulsion Formulation. Journal of Pharmaceutical Sciences. 99(11). 4630–4641. 100 indexed citations

Pagonis, Tom C, Judy Chen, Carla Raquel Fontana, et al.. (2009). Nanoparticle-based Endodontic Antimicrobial Photodynamic Therapy. Journal of Endodontics. 36(2). 322–328. 170 indexed citations

Shah, Lipa, et al.. (2008). A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells. Biotechnology and Bioengineering. 101(5). 1072–1082. 22 indexed citations

Devalapally, Harikrishna, et al.. (2008). Multi-functional nanocarriers for targeted delivery of drugs and genes. Journal of Controlled Release. 130(2). 121–128. 134 indexed citations

Mailavaram, Raghu Prasad, et al.. (2008). Synthesis and Bronchodilator Studies of Some Novel 6-Alkyl/Aryl-1,2,4-Triazino[4,3-]Quinazolines. PubMed. 2(1). 101–111. 3 indexed citations

10.

Devalapally, Harikrishna, et al.. (2008). Enhancement in Anti-proliferative Effects of Paclitaxel in Aortic Smooth Muscle Cells upon Co-administration with Ceramide using Biodegradable Polymeric Nanoparticles. Pharmaceutical Research. 25(8). 1936–1947. 25 indexed citations

11.

Devalapally, Harikrishna, et al.. (2008). Safety, Pharmacokinetics and Biodistribution Studies of a β-galactoside Prodrug of Doxorubicin for Improvement of Tumor Selective Chemotherapy. Drug Development and Industrial Pharmacy. 34(8). 789–795. 15 indexed citations

12.

Ganta, Srinivas, Harikrishna Devalapally, Aliasgar Shahiwala, & Mansoor M. Amiji. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. Journal of Controlled Release. 126(3). 187–204. 1779 indexed citations breakdown →

13.

Devalapally, Harikrishna, Zhenfeng Duan, Michael V. Seiden, & Mansoor M. Amiji. (2008). Modulation of Drug Resistance in Ovarian Adenocarcinoma by Enhancing Intracellular Ceramide Using Tamoxifen-Loaded Biodegradable Polymeric Nanoparticles. Clinical Cancer Research. 14(10). 3193–3203. 96 indexed citations

14.

Devalapally, Harikrishna, Zhenfeng Duan, Michael V. Seiden, & Mansoor M. Amiji. (2007). Paclitaxel and ceramide co‐administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. International Journal of Cancer. 121(8). 1830–1838. 86 indexed citations

15.

Devalapally, Harikrishna, et al.. (2007). Role of Nanotechnology in Pharmaceutical Product Development. Journal of Pharmaceutical Sciences. 96(10). 2547–2565. 154 indexed citations

16.

Devalapally, Harikrishna, et al.. (2007). β-galactoside prodrugs of doxorubicin for application in antibody directed enzyme prodrug therapy/prodrug monotherapy. Archives of Pharmacal Research. 30(6). 723–732. 31 indexed citations

17.

Devalapally, Harikrishna, Dinesh B. Shenoy, Steven R. Little, Róbert Langer, & Mansoor M. Amiji. (2006). Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Cancer Chemotherapy and Pharmacology. 59(4). 477–484. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact